2010
DOI: 10.1159/000297773
|View full text |Cite
|
Sign up to set email alerts
|

European Consensus Guidelines on the Management of Neonatal Respiratory Distress Syndrome in Preterm Infants – 2010 Update

Abstract: These updated guidelines contain new evidence from recent Cochrane reviews and the medical literature since 2007. Many of the previous recommendations regarding early surfactant and CPAP are now more firmly evidence-based. The section on delivery room stabilisation has been considerably expanded. There are new recommendations on delaying umbilical cord clamping and a new section has been added on avoiding or reducing duration of mechanica l ventilation, including recommendations on caf feine t herapy, nasal ve… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
175
0
15

Year Published

2012
2012
2019
2019

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 233 publications
(197 citation statements)
references
References 266 publications
(123 reference statements)
2
175
0
15
Order By: Relevance
“…Treatment with higher doses has been shown to result in lower BPD and mortality, less intraventricular hemorrhage, longer duration of action, faster weaning of oxygen, less air leaks, longer half-life, and less need for re-dosing [78][79][80][81][82]. The European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants [83] recommend an initial dose of 200 mg/kg dose of PA for the treatment of RDS, which is also endorsed by the European Association of Perinatal Medicine.…”
Section: Animal Derived Surfactantsmentioning
confidence: 99%
“…Treatment with higher doses has been shown to result in lower BPD and mortality, less intraventricular hemorrhage, longer duration of action, faster weaning of oxygen, less air leaks, longer half-life, and less need for re-dosing [78][79][80][81][82]. The European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants [83] recommend an initial dose of 200 mg/kg dose of PA for the treatment of RDS, which is also endorsed by the European Association of Perinatal Medicine.…”
Section: Animal Derived Surfactantsmentioning
confidence: 99%
“…1 Respiratory distress syndrome (RDS) is common in preterm infants born at Ͻ 32 weeks of gestational age, [2][3][4] and surfactant and mechanical ventilation have been the standard treatment. 5 However, despite advances in neonatal respiratory care, a considerable number of preterm infants develop chronic lung disease, termed bronchopulmonary dysplasia (BPD), [5][6][7][8] that is associated with neonatal death, prolonged NICU stay, and impaired neurodevelopment. 9 BPD has a multifactorial pathogenesis, and invasive mechanical ventilation is one of its most important causes.…”
Section: Introductionmentioning
confidence: 99%
“…(12)(13)(14) Of the 40 defining characteristics submitted, 26 (65.0%) obtained an agreement greater than 80%.…”
Section: Discussionmentioning
confidence: 99%